Treatment-Resources-for-Providers COVID-19 Treatment Resources for Healthcare Providers

COVID-19 Treatment Resources for Healthcare Providers

​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​

Dr explaining prescription to patient 

There are now multiple products approved by the U.S. Food and Drug Administration (FDA) for the outpatient treatment and authorized for the prevention of COVID-19.  The primary goal of these medications is to reduce hospitalizations and deaths in high-risk patients with COVID-19.  

Providers should have a low threshold to prescribe COVID-19 therapeutics given the broad range of individuals who are at higher risk for severe COVID-19 and can benefit from COVID-19 treatment. 

Please refer to this page and associated links for the latest guidance and resources on COVID-19 therapeutics.​​  

​​

Overview of Antivirals 

Effective treatment for outpatients with mild-to-moderate COVID-19 is available and should be offered to all eligiblepatients.  

The FDA has approved the following medications for treatment of COVID-19: Coronavirus (COVID-19) | Drugs | FDA 


CDC MMWR COVID-19 Antivirals Diagram.png

Originally published on June 15, 2022